SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-143371
Filing Date
2019-05-10
Accepted
2019-05-09 21:15:41
Documents
57
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d727905d10q.htm 10-Q 741941
2 EX-10.1 d727905dex101.htm EX-10.1 12554
3 EX-31.1 d727905dex311.htm EX-31.1 10645
4 EX-31.2 d727905dex312.htm EX-31.2 10628
5 EX-32.1 d727905dex321.htm EX-32.1 6237
12 GRAPHIC g727905g0503194746374.jpg GRAPHIC 3138
  Complete submission text file 0001193125-19-143371.txt   5446566

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gbt-20190331.xml EX-101.INS 1623706
7 XBRL TAXONOMY EXTENSION SCHEMA gbt-20190331.xsd EX-101.SCH 30493
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20190331_cal.xml EX-101.CAL 43721
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20190331_def.xml EX-101.DEF 136253
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20190331_lab.xml EX-101.LAB 307911
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20190331_pre.xml EX-101.PRE 237554
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 19812584
SIC: 2834 Pharmaceutical Preparations